Read More Analyst Ratings Hot News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Coinbase Global, Maintains $425 Price Target By Benzinga Newsdesk October 31, 10:07 AM HC Wainwright & Co. analyst Mike Colonnese reiterates Coinbase Global (NASDAQ:COIN) with a Buy and maintains $425 price target. COIN
Read More Earnings Guidance News Infrastructure and Energy Q1 EPS $(0.56) Misses $(0.12) Estimate, Sales $360.10M Beat $327.96M Estimate; Raises FY22 Sales Guidance To $2.3B-$2.5B vs $2.13B Estimate By Benzinga Newsdesk May 9, 5:25 PM Infrastructure and Energy (NASDAQ:IEA) reported quarterly losses of $(0.56) per share which missed the analyst consensus estimate of $(0.12) by 366.67 percent. This is a 38.46 percent increase over losses of $(0.91) per IEA
Read More Biotech FDA General Health Care News Europe Approves Sanofi’s Expanded Use Of Aubagio In Pediatric Patients With Multiple Sclerosis By Vandana Singh June 18, 3:27 PM The European Commission has approved Sanofi SA’s (NASDAQ:SNY) Aubagio (teriflunomide) for the treatment of pediatric patients 10 to 17 years of… SNY
Read More Analyst Ratings Initiation News Price Target UBS Initiates Coverage On Blend Labs with Neutral Rating, Announces Price Target of $20 By Benzinga Newsdesk August 10, 9:05 AM UBS analyst Karl Keirstead initiates coverage on Blend Labs (NYSE:BLND) with a Neutral rating and announces Price Target of $20. BLND